Latest Breaking News On - Rsys group - Page 1 : vimarsana.com

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesDave chennHui shaoChina century groupMeeting of the companyCompany the boardLakeshore biopharma co ltdChina green energy fundInstitute of technologyCompany the interimCouncil memberUniversity of chicago booth school businessYs biopharma co ltdRsys groupExchange square

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRobin yangHui shaoAlyssa liDave chennRsys groupLakeshore biopharma co ltdCompany the interimCouncil memberCompany the boardSecurities exchangeUniversity of chicago booth school businessCompany registration statement on formChina green energy fundChina century group

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesHui shaoDave chennRobin yangAlyssa liChina green energy fundExchange squareSecurities exchangeCompany the interimPrnewswire ys biopharma co ltdSource ys biopharma co ltdCompany the boardCouncil memberCompany registration statement on formChina century group

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesRobin yangAlyssa liSecurities exchangeNasdaq stock marketPrnewswire ys biopharma co ltdRsys groupSource ys biopharma co ltdExchange commissionCompany registration statement on formReceives additionalRegain complianceMinimum bid priceNasdaq listing ruleNasdaq capital marketBid price requirement

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesRobin yangAlyssa liDavid shaoBrenda wuYs biopharma co ltdChinese centerPeople bankCompany registration statement on formPrnewswire ys biopharma co ltdSecurities exchangeDrug administrationSource ys biopharma co ltdDevelopment expensesExchange rate information